Literature DB >> 25393250

Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients.

Sandy Liu1, Paul Staats, Michael Lee, H Richard Alexander, Allen P Burke.   

Abstract

There are few studies addressing survival of diffuse peritoneal mesotheliomas (DPM).In this study, survival data were obtained retrospectively from 73 patients treated with intended cytoreductive surgery for DPM, with a mean follow-up of 42 months. Mesotheliomas were classified as well differentiated papillary (WDPM, n = 2), multicystic (MCM, n = 4), and epithelioid mesotheliomas were subclassified as tubulopapillary (TPM, n = 27), solid/deciduoid (S/DM, n = 34), and or biphasic mesothelioma (BPM, n = 6). Invasion was characterised as absent (grade 0), into stroma (grade 1), into fat (grade 2), and into adjacent structures (grade 3). Peritoneal cancer index (PCI) and completeness of cytoreduction (CCR) were assessed surgically.There were no deaths in the WDPM, MCM, and epithelioid DPM with ≤ grade 1 invasion. There was a stepwise decrease in overall survival from invasive TPM, S/DM, and BPM (p < 0.0001). By univariate analysis, advanced age (p = 0.01), incomplete CCR (p < 0.001), PCI (p = 0.004), mitotic count (p < 0.001), nuclear grade (p < 0.0001), stromal inflammation (p = 0.013), depth of invasion (p < 0.0001), necrosis (p = 0.002), and sarcomatoid growth (p < 0.0001) were associated with decreased overall survival. By multivariate analysis, only sarcomatoid growth (p = 0.0006), depth of invasion (p = 0.02), elevated CCR (CCR 2-3) (p = 0.02), and presence of inflammatory stroma (p = 0.04) were significant variables associated with decreased overall survival.DPM form a spectrum of indolent to highly aggressive tumours. Solid epithelioid/deciduoid tumours have a prognosis intermediate between biphasic mesotheliomas and invasive TPM. The presence and degree of invasion, sarcomatoid features, and inflammatory stroma are poor prognostic indicators.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25393250     DOI: 10.1097/PAT.0000000000000181

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  20 in total

1.  Unusual presentation of a late-onset recurrence of malignant peritoneal mesothelioma.

Authors:  Marije Wijnberge; Lidewine Daniels; Vincent Cliteur; Jasper Winkelhagen
Journal:  BMJ Case Rep       Date:  2017-03-06

Review 2.  Malignant peritoneal mesothelioma: a review.

Authors:  Joseph Kim; Shanel Bhagwandin; Daniel M Labow
Journal:  Ann Transl Med       Date:  2017-06

3.  Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases.

Authors:  David B Chapel; Jefree J Schulte; Gudrun Absenger; Richard Attanoos; Luka Brcic; Kelly J Butnor; Lucian Chirieac; Andrew Churg; Françoise Galateau-Sallé; Kenzo Hiroshima; Yin P Hung; Hedy Kindler; Thomas Krausz; Alberto Marchevsky; Mari Mino-Kenudson; Jeffrey Mueller; Kazuki Nabeshima; Kirin Turaga; Ann E Walts; Aliya N Husain
Journal:  Mod Pathol       Date:  2020-10-15       Impact factor: 7.842

Review 4.  Imaging spectrum of mesenteric masses.

Authors:  Radwan Diab; Mayur Virarkar; Mohammed Saleh; Sherif Elsheif; Sanaz Javadi; Priya Bhosale; Silvana Faria
Journal:  Abdom Radiol (NY)       Date:  2020-11

Review 5.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Authors:  Michele Carbone; Prasad S Adusumilli; H Richard Alexander; Paul Baas; Fabrizio Bardelli; Angela Bononi; Raphael Bueno; Emanuela Felley-Bosco; Francoise Galateau-Salle; David Jablons; Aaron S Mansfield; Michael Minaai; Marc de Perrot; Patricia Pesavento; Valerie Rusch; David T Severson; Emanuela Taioli; Anne Tsao; Gavitt Woodard; Haining Yang; Marjorie G Zauderer; Harvey I Pass
Journal:  CA Cancer J Clin       Date:  2019-07-08       Impact factor: 508.702

Review 6.  New insights in the pathology of peritoneal surface malignancy.

Authors:  Norman John Carr
Journal:  J Gastrointest Oncol       Date:  2021-04

7.  A case of malignant peritoneal mesothelioma suggesting the utility of combining double-contrast radiography and endoscopy with computed tomography for diagnosis.

Authors:  Hirokazu Saito; Shota Hasuda; Jiro Nasu; Mitsuhiko Kitaoka; Ikuo Matsushita
Journal:  Clin J Gastroenterol       Date:  2017-06-23

Review 8.  Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies.

Authors:  Angela Bononi; Andrea Napolitano; Harvey I Pass; Haining Yang; Michele Carbone
Journal:  Expert Rev Respir Med       Date:  2015-08-26       Impact factor: 3.772

Review 9.  Diagnosis and management of patients with malignant peritoneal mesothelioma.

Authors:  H Richard Alexander; Allen P Burke
Journal:  J Gastrointest Oncol       Date:  2016-02

10.  Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study.

Authors:  Nazim Benzerdjeb; Peggy Dartigues; Vahan Kepenekian; Séverine Valmary-Degano; Eliane Mery; Gerlinde Averous; Anne Chevallier; Marie-Hélène Laverriere; Irène Villa; Françoise Galateau Sallé; Laurent Villeneuve; Olivier Glehen; Sylvie Isaac; Juliette Hommell-Fontaine
Journal:  Virchows Arch       Date:  2021-06-24       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.